These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

770 related articles for article (PubMed ID: 9564569)

  • 1. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.
    White TC; Marr KA; Bowden RA
    Clin Microbiol Rev; 1998 Apr; 11(2):382-402. PubMed ID: 9564569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
    Sanglard D; Kuchler K; Ischer F; Pagani JL; Monod M; Bille J
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medically important fungi respond to azole drugs: an update.
    Zavrel M; White TC
    Future Microbiol; 2015; 10(8):1355-73. PubMed ID: 26234644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal drug resistance in pathogenic fungi.
    Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
    Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antifungal resistance in opportunistic pathogenic fungi (II). Imidazoles and triazoles].
    Martínez-Suárez JV; Rodríguez-Tudela JL
    Enferm Infecc Microbiol Clin; 1996 Oct; 14(8):490-8. PubMed ID: 9011208
    [No Abstract]   [Full Text] [Related]  

  • 6. Resistance mechanisms in clinical isolates of Candida albicans.
    White TC; Holleman S; Dy F; Mirels LF; Stevens DA
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1704-13. PubMed ID: 12019079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance.
    Walsh TJ; Kasai M; Francesconi A; Landsman D; Chanock SJ
    J Med Vet Mycol; 1997; 35(2):133-7. PubMed ID: 9147273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fungal Biofilms: Update on Resistance.
    Borghi E; Borgo F; Morace G
    Adv Exp Med Biol; 2016; 931():37-47. PubMed ID: 27115411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane transporters and antifungal drug resistance.
    St Georgiev V
    Curr Drug Targets; 2000 Nov; 1(3):261-84. PubMed ID: 11465075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal drug resistance of pathogenic fungi.
    Kontoyiannis DP; Lewis RE
    Lancet; 2002 Mar; 359(9312):1135-44. PubMed ID: 11943280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of fungal resistance: an overview.
    Balkis MM; Leidich SD; Mukherjee PK; Ghannoum MA
    Drugs; 2002; 62(7):1025-40. PubMed ID: 11985489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene.
    Sanglard D; Ischer F; Monod M; Bille J
    Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():405-416. PubMed ID: 9043118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetic basis of fluconazole resistance development in Candida albicans.
    Morschhäuser J
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):240-8. PubMed ID: 12084466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fungal resistance in Cambodian children with acquired immunodeficiency syndrome.
    Krcmery V; Augustinova A; Babelova O; Doczeova A; Liskova A
    Pediatr Infect Dis J; 2006 May; 25(5):470. PubMed ID: 16645523
    [No Abstract]   [Full Text] [Related]  

  • 16. Expression of Major Efflux Pumps in Fluconazole-Resistant Candida albicans.
    Pourakbari B; Teymuri M; Mahmoudi S; Valian SK; Movahedi Z; Eshaghi H; Mamishi S
    Infect Disord Drug Targets; 2017; 17(3):178-184. PubMed ID: 28558643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic dissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infection.
    MacCallum DM; Coste A; Ischer F; Jacobsen MD; Odds FC; Sanglard D
    Antimicrob Agents Chemother; 2010 Apr; 54(4):1476-83. PubMed ID: 20086148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New azole antifungals with a fused triazinone scaffold.
    Montoir D; Guillon R; Gazzola S; Ourliac-Garnier I; Soklou KE; Tonnerre A; Picot C; Planchat A; Pagniez F; Le Pape P; Logé C
    Eur J Med Chem; 2020 Mar; 189():112082. PubMed ID: 32000050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaches to fungal diagnosis in transplantation.
    Patterson TF
    Transpl Infect Dis; 1999 Dec; 1(4):262-72. PubMed ID: 11428997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired resistance or tolerance? - in search of mechanisms underlying changes in the resistance profile of Candida albicans and Candida parapsilosis as a result of exposure to methotrexate.
    Góralska K; Szybka M; Karuga FF; Pastuszak-Lewandoska D; Brzeziańska-Lasota E
    J Mycol Med; 2024 Jun; 34(2):101476. PubMed ID: 38507825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.